Prognostic significance of graft Foxp3 expression in renal transplant recipients: A critical review and attempt to reconcile discrepancies

Nephrology Dialysis Transplantation

Volumn 28, Issue 5, 2013, Pages 1100-1111

  Zuber, Julien ^a   Grimbert, Philippe ^b   Blancho, Gilles ^c   Thaunat, Oliver ^d   Durrbach, Antoine ^e   Baron, Christophe ^f   Lebranchu, Yvon ^f  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e BICÊTRE HOSPITAL   (France)

^f UNIVERSITÉ DE TOURS   (France)

Author keywords

biomarker; graft biopsy; tolerance; transplantation; Treg

Indexed keywords

ALEMTUZUMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; FAS LIGAND; INTERLEUKIN 10; INTERLEUKIN 35; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRAFT REJECTION; ANTIBODY MEDIATED REJECTION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CHRONIC ALLOGRAFT NEPHROPATHY; CYTOKINE RELEASE; CYTOLYSIS; DENDRITIC CELL; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MEMORY T LYMPHOCYTE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; T CELL DEPLETION;

BIOMARKER; GRAFT BIOPSY; TOLERANCE; TRANSPLANTATION; TREG;

ANIMALS; BIOLOGICAL MARKERS; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 84878000157     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs570     Document Type: Article

References (88)

1. Gershon RK, Kondo K. Infectious immunological tolerance. Immunology 1971; 21: 903-914
2. Sakaguchi S, Yamaguchi T, Nomura T et al. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787
3. Gilliet M, Liu Y-J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002; 195: 695-704
4. Bilate AM, Lafaille JJ. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu Rev Immunol 2012; 30:733-758
5. Seddon B, Mason D. The third function of the thymus. Immunol Today 2000; 21: 95-99
6. Walker RM, Kasprowicz DJ, Gersuk VH et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest 2003; 112: 1437-1443
7. Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009; 30: 626-635
8. Maganto-García E, Bu D-X, Tarrio ML et al. Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment. J Immunol 2011; 187: 3521-3529
9. Fan Z, Spencer JA, Lu Y et al. In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response. Nat Med 2010; 16: 718-722
10. Josefowicz SZ, Niec RE, Kim HY et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 2012; 482: 395-399
11. Samstein RM, Josefowicz SZ, Arvey A et al. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 2012; 150: 29-38
12. Schlenner SM, Weigmann B, Ruan Q et al. Smad3 binding to the Foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J Exp Med 2012; 209: 1529-1535
13. Vukmanovic-Stejic M, Zhang Y, Cook JE et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006; 116: 2423-2433
14. Schwele S, Fischer AM, Brestrich G et al. Cytomegalovirus-specific regulatory and effector T cells share TCR clonality-poss-ible relation to repetitive CMV infections. Am J Transplant 2012; 12: 669-681
15. Zhang N, Schröppel B, Lal G et al. Regulatory T cells sequentially migrate from the site of tissue inflammation to the draining LN to suppress the alloimmune response. Immunity 2009; 30: 458-469
16. Menning A, Höpken UE, Siegmund K et al. Distinctive role of CCR7 in migration and functional activity of naive-and effector/memory-like Treg subsets. European Journal of Immunology 2007; 37: 1575-1583
17. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603-606
18. Kilshaw PJ, Brent L, Pinto M. Suppressor T cells in mice made unresponsive to skin allografts. Nature 1975; 255: 489-491
19. Jun L, Kailun Z, Aini X et al. Combined treatment with chemo-kine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation. The Journal of Heart and Lung Transplantation 2010; 29: 461-470
20. Bozulic LD, Wen Y, Xu H et al. Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants. Transplantation 2011; 91: 908-915
21. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199-210
22. Wood KJ, Bushell A, Jones ND. Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells. Immunol Rev 2011; 241: 119-132
23. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061
24. Mantel P-Y, Ouaked N, Rückert B et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 2006; 176: 3593-3602
25. Basu S, Golovina T, Mikheeva T et al. Foxp3 mediated induction of Pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 2008; 180: 5794-5798
26. Torrealba JR, Katayama M, Fechner JH et al. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-ß1+CD4+ T regulatory cell infiltrates. J Immunol 2004; 172: 5753-5764
27. Poirier N, Azimzadeh AM, Zhang T et al. Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation. Sci Transl Med 2010; 2: 17ra10
28. Hernandez-Fuentes MP, Lechler RI. A 'biomarker signature' for tolerance in transplantation. Nat Rev Nephrol 2010; 6: 606-613
29. Facciabene A, Santoro S, Coukos G Know thy enemy: why are tumor-infiltrating regulatory T cells so deleterious? Oncoimmu-nology2012; 1: 575-577
30. Clark RA, Huang SJ, Murphy GF et al. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med 2008; 205: 2221-2234
31. Carroll RP, Segundo DS, Hollowood K et al. Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J Am Soc Nephrol 2010; 21: 713-722
32. Dijke IE, Weimar W, Baan CC Regulatory T cells after organ transplantation: where does their action take place? Hum Immunol 2008; 69: 389-398
33. Muthukumar T, Dadhania D, Ding R et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005; 353: 2342-2351
34. Kollins D, Stoelcker B, Hoffmann U et al. FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection. Clin Nephrol 2011; 75: 91-100
35. Veronese F, Rotman S, Smith RN et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant 2007; 7: 914-922
36. Yapici U, Bemelman FJ, Scheepstra CG et al. Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome. Transplantation 2009; 87: 1377-1380
37. Batsford S, Dickenmann M, Dürmüller U et al. Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful? Clin Nephrol 2011; 75: 101-106
38. Bunnag S, Allanach K, Jhangri GS et al. FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant 2008; 8: 1423-1433
39. Taflin C, Nochy D, Hill G et al. Regulatory T cells in kidney allo-graft infiltrates correlate with initial inflammation and graft function. Transplantation 2010; 89: 194-199
40. Mansour H, Homs S, Desvaux D et al. Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change. J Am Soc Nephrol 2008; 19: 2277-2281
41. Grimbert P, Mansour H, Desvaux D et al. The regulatory/cyto-toxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation 2007; 83: 341-346
42. Bestard O, Cruzado JM, Rama I et al. Presence of FoxP3+ regulatory T cells predicts outcome of subclinical rejection of renal allo-grafts. J Am Soc Nephrol 2008; 19: 2020-2026
43. Bestard O, Cuñetti L, Cruzado JM et al. Intragraft regulatory T cells in protocol biopsies retain Foxp3 demethylation and are protective biomarkers for kidney graft outcome. Am J Transplant 2011; 11: 2162-2172
44. Louis S, Braudeau C, Giral M et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398-407
45. Akl A, Jones ND, Rogers N et al. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Transpl Int 2008; 21: 65-73
46. Braudeau C, Racape M, Giral M et al. Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulat-ory properties in long-term graft outcome. Transpl Int 2007; 20: 845-855
47. Zuber J, Brodin-Sartorius A, Lapidus N et al. FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis. Nephrol Dial Transplant 2009; 24: 3847-3854
48. Belkaid Y, Piccirillo CA, Mendez S et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507
49. Maul J, Loddenkemper C, Mundt P et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005; 128: 1868-1878
50. Thaunat O, Nicoletti A. Lymphoid neogenesis in chronic rejection. Curr Opin Organ Transplant 2008; 13: 16-19
51. Ashton-Chess J, Dugast E, Colvin RB et al. Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol 2009; 20: 1113-1122
52. Deteix C, Attuil-Audenis V, Duthey A et al. Intragraft Th17 Infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 2010; 184: 5344-5351
53. Bestard O, Cruzado JM, Mestre M et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007; 179: 4901-4909
54. 0Intrahepatic detection of FOXP3 gene expression after liver transplantation using minimally invasive aspiration biopsy. Transplantation 2007; 83: 819-823
55. Aquino-Dias EC, Joelsons G, da Silva DM et al. Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function. Kidney Int 2008; 73: 877-884
56. Miyara M, Yoshioka Y, Kitoh A et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911
57. Taflin C, Miyara M, Nochy D et al. FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol 2009; 174: 497-508
58. Zuber J, Viguier M, Lemaitre F et al. Severe FOXP3+ and naïve T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency. Gastroenterology 2007; 132: 1694-1704
59. Gavin MA, Torgerson TR, Houston E et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006; 103: 6659-6664
60. Pillai V, Ortega SB, Wang CK et al. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007; 123: 18-29
61. Kmieciak M, Gowda M, Graham L et al. Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Transl Med 2009; 7: 89
62. Toker A, Huehn J. To be or not to be a Treg cell: lineage decisions controlled by epigenetic mechanisms. Sci Signal 2011; 4: pe4
63. Baron U, Floess S, Wieczorek G et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007; 37: 2378-2389
64. Akimova T, Kamath BM, Goebel JW et al. Differing effects of ra-pamycin or calcineurin inhibitor on T-regulatory cells in pedi-atric liver and kidney transplant recipients. Am J Transplant 2012
65. Wieczorek G, Asemissen A, Model F et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009; 69: 599-608
66. Yang X-P, Ghoreschi K, Steward-Tharp SM et al. Opposing regulation of the Il17 locus through direct, reciprocal actions of STAT3 and STAT5. Nat Immunol 2011; 12: 247-254
67. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033-1036
68. Korn T, Reddy J, Gao W et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007; 13: 423-431
69. Ehrenstein MR, Evans JG, Singh A et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004; 200: 277-285
70. Pearl JP, Parris J, Hale DA et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005; 5: 465-474
71. Neujahr DC, Chen C, Huang X et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006; 176: 4632-4639
72. Lakkis FG, Sayegh MH. Memory T cells: a hurdle to immunolo-gic tolerance. JASN 2003; 14: 2402-2410
73. Gurkan S, Luan Y, Dhillon N et al. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant 2010; 10: 2132-2141
74. Broady R, Yu J, Levings MK. ATG-induced expression of FOXP3 in human CD4+ T cells in vitro is associated with T-cell activation and not the induction of FOXP3+ T regulatory cells. Blood 2009; 114: 5003-5006
75. Cobbold SP, Castejon R, Adams E et al. Induction of FoxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 2004; 172: 6003-6010
76. Wu Z, Bensinger SJ, Zhang J et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004; 10: 87-92
77. Flechner SM, Friend PJ, Brockmann J et al. Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression. Am J Transplant 2005; 5: 3009-3014
78. Serres SAD, Sayegh MH, Najafian N. Immunosuppressive drugs and tregs: a critical evaluation! CJASN 2009; 4: 1661-1669
79. Wu Y, Borde M, Heissmeyer V et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006; 126: 375-387
80. Kang HG, Zhang D, Degauque N et al. Effects of cyclosporine on transplant tolerance: the role of IL-2. Am J Transplant 2007; 7: 1907-1916
81. Haasch D, Chen Y-W, Reilly RM et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immuno-suppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol 2002; 217: 78-86
82. Lu L-F, Thai T-H, Calado DP et al. Foxp3-dependent micro-RNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009; 30: 80-91
83. Fourtounas C, Dousdampanis P, Sakellaraki P et al. Different im-munosuppressive combinations on T-cell regulation in renal transplant recipients. Am J Nephrol 2010; 32: 1-9
84. Gao W, Lu Y, El Essawy B et al. Contrasting effects of cyclospor-ine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 2007; 7: 1722-1732
85. Presser D, Sester U, Mohrbach J et al. Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens. Kidney Int 2009; 76: 557-566
86. Wang H, Zhao L, Sun Z et al. A potential side effect of cyclospor-in A: inhibition of CD4(+)CD25(+) regulatory T cells in mice. Transplantation 2006; 82: 1484-1492
87. Haxhinasto S, Mathis D, Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med 2008; 205: 565-574
88. Zuber J, Hermine O, Chatenoud L et al. Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality? Curr Opin Organ Transplant 2011; 16: 606-613